| Year |
Citation |
Score |
| 2024 |
Bai JPF, Liu G, Zhao M, Wang J, Xiong Y, Truong T, Earp JC, Yang Y, Liu J, Zhu H, Burckart GJ. Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report. Cpt: Pharmacometrics & Systems Pharmacology. PMID 39423143 DOI: 10.1002/psp4.13208 |
0.326 |
|
| 2017 |
Wang DD, Yu Y, Kassir N, Zhu M, Hanley WD, Earp JC, Chow AT, Gupta M, Hu C. The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation. Journal of Clinical Pharmacology. PMID 28513856 DOI: 10.1002/jcph.921 |
0.578 |
|
| 2015 |
Lon HK, DuBois DC, Earp JC, Almon RR, Jusko WJ. Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats. Pharmacology Research & Perspectives. 3: e00169. PMID 26516581 DOI: 10.1002/Prp2.169 |
0.582 |
|
| 2014 |
Chow AT, Earp JC, Gupta M, Hanley W, Hu C, Wang DD, Zajic S, Zhu M. Utility of population pharmacokinetic modeling in the assessment of therapeutic protein-drug interactions. Journal of Clinical Pharmacology. 54: 593-601. PMID 24272952 DOI: 10.1002/jcph.240 |
0.592 |
|
| 2013 |
Kenny JR, Liu MM, Chow AT, Earp JC, Evers R, Slatter JG, Wang DD, Zhang L, Zhou H. Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop. The Aaps Journal. 15: 933-40. PMID 23794076 DOI: 10.1208/s12248-013-9495-1 |
0.595 |
|
| 2010 |
Ghoshal S, Rao I, Earp JC, Jusko WJ, Wetzler M. Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity. Cancer Chemotherapy and Pharmacology. 66: 681-9. PMID 20035426 DOI: 10.1007/S00280-009-1210-7 |
0.388 |
|
| 2009 |
Earp JC, Dubois DC, Almon RR, Jusko WJ. Quantitative dynamic models of arthritis progression in the rat. Pharmaceutical Research. 26: 196-203. PMID 18758921 DOI: 10.1007/S11095-008-9711-3 |
0.481 |
|
| 2008 |
Earp JC, Pyszczynski NA, Molano DS, Jusko WJ. Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis. Biopharmaceutics & Drug Disposition. 29: 366-72. PMID 18613033 DOI: 10.1002/Bdd.626 |
0.502 |
|
| 2008 |
Earp JC, Dubois DC, Molano DS, Pyszczynski NA, Keller CE, Almon RR, Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats. The Journal of Pharmacology and Experimental Therapeutics. 326: 532-45. PMID 18448865 DOI: 10.1124/Jpet.108.137372 |
0.559 |
|
| 2008 |
Earp JC, Dubois DC, Molano DS, Pyszczynski NA, Almon RR, Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis. The Journal of Pharmacology and Experimental Therapeutics. 326: 546-54. PMID 18448864 DOI: 10.1124/Jpet.108.137414 |
0.581 |
|
| 2007 |
Wetzler M, Earp JC, Brady MT, Keng MK, Jusko WJ. Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2261-70. PMID 17404111 DOI: 10.1158/1078-0432.Ccr-06-2468 |
0.418 |
|
| 2006 |
Drake AS, Michael BT, Wang XH, Sait SJ, Earp JC, Jusko WJ, Ferrone S, Wang ES, Wetzler M. The Effects of Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Monoclonal Antibodies (mAb) Against 11q23 Positive Acute Leukemia Cells. Blood. 108: 4550-4550. DOI: 10.1182/Blood.V108.11.4550.4550 |
0.441 |
|
| 2004 |
Earp J, Krzyzanski W, Chakraborty A, Zamacona MK, Jusko WJ. Assessment of drug interactions relevant to pharmacodynamic indirect response models. Journal of Pharmacokinetics and Pharmacodynamics. 31: 345-80. PMID 15669772 DOI: 10.1007/S10928-004-8319-4 |
0.621 |
|
| Show low-probability matches. |